2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
4
Urinary Bladder Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Disease
2
Colorectal Neoplasms
2
Acute Kidney Injury
2
Tuberous Sclerosis
1
Spinal Cord Injuries
1
Smoldering Multiple Myeloma
1
Salivary Gland Adenoma, Pleomorphic
1
Renal Insufficiency
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Hemangiosarcoma
1
Glioma
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Lenalidomide
17
Dexamethasone
15
Calcium Dobesilate
8
daratumumab
5
dexamethasone acetate
4
dexamethasone 21-phosphate
4
carfilzomib
4
auricularum
4
Melphalan
4
Leflunomide
3
Curcumin
3
isatuximab
2
iberdomide
2
elotuzumab
2
Peripheral Blood Stem Cell Transplantation
2
PVX-410 vaccine
2
Denosumab
2
Cyclophosphamide
2
Bortezomib
2
siltuximab
1
selinexor
1
sargramostim
1
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Urination
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts